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Abstract 
 
With a rapidly expanding older population and increased survival of older 
people with chronic disease we can expect to see increasing numbers of people 
with orthostatic hypotension (OH).  Unfortunately the evidence-base for people 
with OH, with particular relevance to older people, has not kept up and has 
resulted in a real lack of progress and little good evidence.  There are several 
areas of research that could potentially benefit patients but establishing which 
ones are priority areas requires Public & Patient Involvement (PPI).  This 
process includes people/patients in the research team to maximise the 
relevance, success and translation of the research.  This brief report describes 
the early involvement of older people in prioritising the research question, 
methods to improve adherence during a trial and the preferred methods to 
disseminate research output.  The individuals’ priority was to research non-
pharmacological treatment strategies and to improve the education of patients 
about their condition.  Education was felt to be the best strategy to promote 
adherence during a trial, with change in symptoms and quality of life felt to be 
the most important outcome measures as opposed to blood pressure.  This 
report offers guidance for academics that are undertaking OH-related research 
and how they can improve its relevance and increase its translation into clinical 
practice.  
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Introduction 
 
Orthostatic hypotension (OH) is a common condition affecting 7% of 
community-dwelling older people and up to 70% of people in long-term care [1]. 
However, despite the high prevalence there is very little evidence base 
underpinning the pathophysiology, diagnosis, management and prognosis, with 
evidence being even more rare when specifically required for older people [2]. 
OH is an important area for research because it has a heavy symptomatic burden, 
is associated with falls, depression and cognitive impairment and is also 
associated with an increase in mortality [3 4]. 
 
In order to deliver high quality research it is now recognised that involvement of 
patients and the public should be a priority.  Indeed, all UK National Institute for 
Health Research (NIHR) Research Programmes now encourage this because it is 
well established that Public and Patient Involvement (PPI) leads to better 
research, clearer outcomes and faster translation [5 6]. 
 
Given the lack of evidence for OH, there is a need to prioritise which areas of 
research require the most attention. PPI is the ideal method to establish the 
patient and public priorities but can also be used to promote adherence, 
retention, dissemination and select appropriate outcome measures and improve 
dissemination of results.  This paper presents the involvement of older people 
with OH participating in the early phases of research planning. 
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Methods 
 
PPI is not research, rather it is consultation/collaboration, as such there is no 
strict methodology, analysis or approvals process.  However, here we describe 
the processes involved and the outcomes in the format typical of a research 
paper. 
 
Patients were invited to become involved in the discussion about OH related 
research via an independent charity.  Involve North East (InvolveNE), is based in 
North East of England and specialises in innovative methods to involve patients 
and public in all aspects of research and service commissioning and design [7].  
Their population databases may offer broader and more diverse groups of 
people than would be gained from a hospital clinic or primary care, in particular, 
hard-to-reach groups. 
 
Those invited to be involved were aged over 60 years, had a diagnosis of OH 
were able to hold the discussion in English and agreed to discussions being 
recorded and transcribed. Those who expressed an interest were invited either 
to a group meeting or to have an individual discussion. 
 
A member of InvolveNE, experienced in qualitative interview skills, performed 
semi-structured interviews.  No members of the research team were involved at 
this stage, thereby reducing bias.  Broad topics of discussion, which were 
predefined by clinical academics, were: 
 Research priorities for people with OH 
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 Using non-drug or pharmacological treatments for OH 
 Strategies to improve adherence with treatments 
 Outcome measures to assess effectiveness of treatments 
 Including older people with OH on the research team 
 
Results 
Of 250 community groups that were contacted, seven responded and agreed to a 
visit from InvolveNE.  One focus group of two people was performed and three 
individual interviews were conducted.  One person declined to give their age, but 
confirmed that they were aged over 60 years; the remaining four were aged over 
60 years with one male and four females.  All had OH, were White British and 
resided in non-affluent inner city areas. 
 
PRIORITY 1 
Although all five individuals understood the importance of researching the 
pathophysiology, diagnostic methods and prognosis of OH, their principle 
research priority was for the treatment of OH.  Interestingly, four of the five 
people expressed a preference for researching non-drug treatments for OH: 
 
“treatment would be good but not more medication, I already take enough 
medication” 
 
Given that non-drug treatments generally have poor adherence, the individuals 
were asked how this could be improved during the course of a clinical trial.  The 
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overall consensus was that if a treatment worked then people would adhere to it, 
with one person giving a limit of 4 weeks to allow something chance to work.   
 
PRIORITY 2 
After gentle prompting, all five people said that understanding more about how 
treatments work would improve adherence, with two specifying that this 
explanation would be better from people with OH rather than clinicians, who in 
their experience spoke in medical jargon.  A frustration at the lack of 
understanding of their condition and the complexity of the information given to 
them was a common theme.  Individuals described the use of medical jargon by 
clinicians and felt that if information was provided by people who have OH, such 
as in the design of leaflets, then adherence would improve and frustrations 
decrease. 
 
“Explaining it in plain English because sometimes you get stuff through the post 
and it's got loads of long medical words and I don't know what that means” 
 
OUTCOME MEASURES 
Four people thought a clinical trial should assess response to treatment by 
measuring symptoms and one specified ability to perform everyday activities.  
This is in contrast to usual practice where measures of blood pressure are 
standard [8]. 
 
PPI 
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All five individuals thought that involving people with OH in the research team 
would be highly beneficial. 
 
“I think it's a good idea to have someone who fully understands what it's like on the 
team, I would trust them more” 
 
DISSEMINATION 
On discussing whether people would be interested in the results of research, all 
would like to be informed of the results.  When asked how they think this could 
be done, two people specified receiving the results in a newsletter, however one 
said they would prefer something more social, like a coffee morning.  Another 
suggested having an animation on the Internet and being kept informed 
throughout the trial, rather than just at the end. 
 
Discussion 
The discussions presented here highlight the research priorities for a group of 
patients with OH who would not normally be involved in the research process.  
Older people are often excluded from research as a result of co-morbidity, poly-
pharmacy and possible misplaced judgements about vulnerability [9].  Studies 
involving older people may also face greater challenges with recruitment, 
retention and long-term follow-up when compared to trials involving only 
younger people [9]. 
 
PPI is the initial step in identifying the research priorities for older people with 
OH.  The discussions presented here demonstrate that the greatest priority is an 
Page 8 of 12 
 
effective treatment for the symptoms of OH with a preference for non-
pharmacological intervention.  This is an important message for academics 
involved in the research of OH.  It is easy for academics to have a paternalistic 
attitude, investigating what we feel is most important, often following the 
structure of the archaic ‘surgical sieve’.  However, this paternalism is not 
acceptable for publically funded research, rather the priorities should be 
established together, with patients and academics working together as a 
research team.  This approach improves the quality of clinical research and it’s 
translation into clinical practise [10].  
 
In general, non-drug treatments for chronic conditions have poor adherence and 
clinical experience shows that this is true for the treatment of OH [11].  The PPI 
presented here provides new insights into potential strategies to improve 
adherence to these treatments.  An understanding of the treatment was felt to 
offer the most potential; provided it is explained in jargon-free language.  
Involving patients and the public in the design of and writing of an educational 
resource would be a useful way to address this and would improve the 
understanding of the proposed treatment. 
 
The predominant outcome measures used in studies relating to OH are all based 
on absolute BP values.  In only a small number of trials are symptoms or quality 
of life used as an outcome measure, and in those cases as a secondary measure.  
However, the patients involved in these discussions clearly prefer change in 
symptoms or functional ability as an outcome measure.  There are very few OH-
specific symptom and quality of life measures, with no validation studies for use 
Page 9 of 12 
 
in older people [12 13].  This is urgently needed to advance the quality of 
outcome measures in OH-related trials. 
 
It is important to recognise that PPI is not solely to improve recruitment and 
dissemination strategies.  Patients or public representatives can be involved in 
all aspects of the research process including protocol design, analysis and 
participating on the project steering group.  All individuals who contributed to 
the discussions presented here appreciated this and felt that such involvement 
would improve the quality of the research. 
 
A sample size of five may be considered as very small for a research study, but it 
is worth bearing in mind that this is not a research study, rather a consultation 
exercise.  However, it is important to recognise that the views expressed in this 
piece of PPI may not represent the views of all older people with OH.  Notably, 
those involved in this discussion were all community-dwelling, white British and 
from inner city communities.  As we do not have data concerning comorbidities, 
precise ages and underlying pathophysiology we are unable to claim that the 
views stated here can represent the OH population as a whole.  Nevertheless, we 
are able to share our experiences of the PPI process with other clinicians and 
academics involved in the care of and research for older people. 
 
An interesting finding from this study, for others considering undertaking PPI, is 
that the older people invited to partake were not keen on group meetings, 
preferring to have individual discussion. This is relevant for those who wish to 
involve hard-to-reach groups as it demonstrates that there are people willing to 
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become involved in research who do not feel comfortable in the typical patient 
group environment. This may help researchers when involving patients and the 
public in their research to consider how to work with and recruit beyond the 
typical expert patient.  
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